Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Trading update – guidance for full year unchanged

18th Nov 2026 07:00

RNS Number : 5781D
Melrose Industries PLC
18 November 2026
 

18 November 2026

 

MELROSE INDUSTRIES PLC

 

Trading update – guidance for the full year unchanged

 

Melrose Industries PLC ("Melrose" or "the Group") announces the following trading update for the four-month period from 1 July to 31 October 2026 (“the Period”). Growth rates are calculated at constant currency and, unless otherwise stated, include the impact from the Garden Grove incident.

 

Peter Dilnot, Chief Executive Officer of Melrose said:

 

“We delivered a solid performance in line with our expectations and made significant progress commercially and operationally in both divisions. We are executing our plan to restart acrylic production at our Garden Grove facility and, having received approval from all applicable authorities, look forward to resuming full operations soon. Throughout the remainder of the important final quarter, our focus remains on operational execution and delivering for our customers.”

 

Trading performance

 

Revenue growth

26 vs 25

25 vs 24

 

 

Q1

H1

Jul-Oct

YTD

 

Jul-Oct

 

Engines

20%

19%

3%

12%

 

28%

 

Airframes

4%

4%

5%

4%

 

5%

 

Group

11%

10%

4%

8%

 

14%

 

 

 

 

 

 

 

 

 

Excluding Garden Grove

 

 

 

 

 

 

 

Airframes

 

 

9%

7%

 

 

 

Group

 

 

6%

9%

 

 

 

 

Group

 

Group revenue growth of 4% in the Period was in line with our expectations, with Engines up 3% and Airframes up 5%. On a year-to-date basis to the end of October, Group revenue increased by 8%, with growth of 12% and 4% in Engines and Airframes respectively. Adjusted operating profit for the Period was in line with our expectations.

 

Engines

 

In Engines, revenue growth of 3% in the Period was against a particularly strong prior year comparator which benefited from the recovery in tariff-related backlogs, where revenue grew 28%. Aftermarket growth of 7% included continued strong performance in both parts repair and governmental, with low double-digit growth in our RRSP portfolio. Variable consideration was flat.

 

OE revenue was 2% lower, reflecting the timing of major engine programme deliveries and very strong OE growth of 35% in the prior period. The two-year compound average growth rate for OE and aftermarket for the Period was 15% and 14% respectively.

 

The division continued to make good progress across a number of commercial and operational areas including: a long-term collaboration agreement with Saab covering the Gripen E/F propulsion system; a three year contract with GE Aerospace for CF34-10 fan blade repairs at our San Diego facility; and the start of construction on the North Charlestown facility expansion, a US$16 million investment that will increase capacity for critical aero-engine components. At the end of the Period, we became the first company in the world to achieve Nadcap accreditation for Laser Wire Directed Energy Deposition, marking an important milestone in the industrialisation of additive fabrication for large-scale aerospace and defence applications.  

 

Airframes

 

Airframes revenue grew 5% in the Period, with growth of 7% in Civil driven by narrow body platforms. Growth in Defence of 2% was dampened by the impact of lower production volumes at our Garden Grove facility following the incident in May. Excluding Garden Grove, Airframes revenue was 9% ahead of the comparative period.

 

During the Period, we continued to develop a number of commercial initiatives notably in Defence, where our advanced manufacturing and technical capabilities continue to be in demand. In July, we announced our participation in BAE Systems’ Collaborative Combat Aircraft prototype, Brontanax, where we are the design and manufacturing partner for the flight-ready wings, fins and control surfaces. In August, less than a year after launching a collaborative programme with the Swedish Defence Materiel Administration, we  unveiled a ‘clean sheet’ uncrewed UAV demonstrator. This brought together propulsion, aerostructures and systems integration expertise from across the Group in Sweden, the Netherlands and the UK.

 

Looking ahead, we will continue to expand production and actively manage our supply chain. We remain well placed to support our OEM customers to meet increasing build rates and with the development of new platforms across both civil and defence.

 

Update on GKN Aerospace’s Garden Grove facility

 

On 16 November, we were pleased to obtain approval from all applicable authorities to restart full operations at the facility. With the ramp-up process well underway, we anticipate resuming acrylic production shortly with a phased return to normalised volume output during the first part of 2027.

 

The approval to restart follows the Orange County Superior Court’s approval of the resolution of the District Attorney’s Office’s civil investigation on 19 October. On 27 October, the claims programme for eligible individuals, households, and businesses for certain losses resulting from the May evacuation opened for submissions.

 

We continue to engage in mediation discussions regarding the various pending civil class action lawsuits. As previously announced, our associated insurance position remains under review.

 

Alongside today’s announcement we have published an Aide Memoire which provides the latest estimate of the financial impact in 2026 including operational and exceptional costs. These costs are also provided as an appendix to this announcement.

 

Refinancing

 

On 4 November, we completed the scheduled refinancing of the Group, securing new, three-year multi-currency bank facilities on investment grade quality terms. The refinancing was supported by nineteen banks across four facilities and secures total funding of c.£2.4 billion, increasing the Group’s total headroom by £0.2 billion. The lower and upper ends of the margin range on the new facilities have also been reduced by 20 basis points and 65 basis points respectively, with the Group’s financial covenants unchanged.

 

Outlook and full year guidance

 

During the remainder of the important fourth quarter, we will continue to focus on operational and commercial execution and delivering for our customers.

 

Excluding the impact of the Garden Grove incident, our guidance for the full year, which assumes an average exchange rate[1] of 1 GBP = US$1.37, is unchanged:

 

Revenue range of £3,750 million to £3,950 millionAdjusted operating profit range of £700 million to £750 millionFree cash flow generation of £150 million to £200 million (after interest and tax)

 

Full year results for 2026 will be published on Friday 26 February 2027.

 

Enquiries:

 

Investor Relations:

 

Mat Wootton: +44 (0) 7483 961 233; [email protected]

 

Media:

 

Simon Sporborg

 

Brunswick: +44 (0) 207 404 5959; [email protected]

GARDEN GROVE FINANCIAL IMPACT

 

£m (US$1.37)

 

H1 2026A

H2 2026E

FY 2026E

Operational impact

 

 

 

Revenue

(16)

(35-40)

(50-55)

Operating profit

(9)

(30-35)

(40-45)

Cash

+12

(35-40)

(25-30)

Exceptional costs

 

 

 

Claims programme (up to $100 million)

 

 

 

P&L

-

c.(73)

c.(73)

Cash

-

c.(7)

c.(7)

Legal and other costs

 

 

 

P&L

(13)

(30-35)

(45-50)

Cash

(5)

(30-35)

(35-40)

Fines and penalties

 

 

 

P&L

-

c.(18)

c.(18)

Cash

-

-

-

Total cash impact

+7

(75-85)

(70-80)

 

 


[1] A 1 cent change in the USD or Euro in isolation would result in adjusted operating profit moving by £5 million and £1 million respectively; and gross debt by £11 million and £2 million respectively.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPGMGGUPQPGM

Related Shares:

Melrose
FTSE 100 Latest
Value10,551.17
Change-138.70